|Bid||0.7377 x 900|
|Ask||0.7400 x 1200|
|Day's Range||0.7040 - 0.8699|
|52 Week Range||0.3200 - 1.5700|
|Beta (5Y Monthly)||2.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 10, 2023 - May 15, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 18, 2012|
|1y Target Est||2.65|
Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 33.33% and 5.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
BOSTON, March 22, 2023--Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
BOSTON, March 17, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the fourth quarter and full year 2022 financial results and provide a corporate update on Wednesday, March 22, 2023, at 8:30 a.m. Eastern/5:30 a.m. Pacific.